Viewing nowCombinationZepogaduo Sustained Release Tablet 10/1000 mg
Dapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.

MFDS item code 202108082 · Approved 2021.12.23 · Insurance code 645406090
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps improve blood sugar control in adult patients with type 2 diabetes using a combination of dapagliflozin and metformin. It is administered as an adjunct to diet and exercise for patients. Patients with cardiovascular disease or risk factors for cardiovascular disease, whose blood sugar is not sufficiently controlled, should consult specialists about the impact of dapagliflozin on the occurrence of cardiovascular events. This medication is used to effectively improve blood sugar control.
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as two 5mg/1000mg tablets. Patients with no prior history of antidiabetic drug therapy who have difficulty achieving adequate glycemic control with monotherapy: When used as initial therapy in patients with no prior history of antidiabetic drug therapy, the recommended starting dose of this medicine is one 5mg/500mg or 10mg/500mg tablet once daily. Titrate the dose gradually to reduce gastrointestinal adverse reactions to metformin. For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this medicine should provide the dose of metformin the patient was taking or an appropriately adjusted dose therapeutically close to it. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately. For patients switching from combination therapy with dapagliflozin and metformin to this medicine, treatment with this medicine may be initiated at the doses of dapagliflozin and metformin previously administered. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately. When this medicine is used concomitantly with insulin or an insulin secretagogue, such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering drugs. Since such a change may cause changes in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under careful monitoring. This medicine must be swallowed whole and must never be crushed, cut, or chewed. Occasionally, inactive ingredients in this medicine may be excreted in the stool as a soft, hydrated mass that resembles a tablet. Renal impairment No dose adjustment is required in patients with mild renal impairment. For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or higher and less than 60 mL/min/1.73 m2 who do not have other symptoms that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, an ingredient in this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medicine is not recommended in patients with an eGFR below 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, administration of this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months. Older adults Because metformin is excreted by the kidneys and renal function is more likely to decline in older adults, this medicine should be used with caution as age increases (see Precautions for Use, 9. Administration to Older Adults).
This medication is used for the treatment of type 2 diabetes and helps lower blood sugar. It contains two components, metformin and dapagliflozin. Metformin controls blood sugar and improves insulin resistance, while dapagliflozin helps lower blood sugar by allowing glucose to be excreted in urine through the kidneys. When taking this medication, it is essential to confirm that kidney function is normal. Patients with impaired kidney function or certain acute illnesses should not take this medication. There is a very rare but serious side effect known as lactic acidosis, which can be life-threatening, so if symptoms arise, medical consultation should be sought immediately. In addition, caution is needed as there is a risk of hypoglycemia when taken with insulin or sulfonylurea medications. This medication should not be given to patients with conditions such as dehydration, severe infections, acute myocardial infarction, heart failure, and the medication should be discontinued for a certain period before and after surgery. Women who are pregnant or breastfeeding should not use this medication. During treatment, genital infections or urinary tract infections may occur, so if these symptoms appear, the patient should inform a doctor immediately. Symptoms of decreased fluid volume or low blood pressure may occur, so elderly patients or those on diuretics should carefully monitor blood pressure and hydration status. This medication may lower vitamin B12 levels, so it is advisable to check vitamin B12 status through blood tests if taken for a long time. Excessive alcohol intake may increase the risk of side effects, so it should be avoided. Regular monitoring of kidney function and blood sugar status is necessary during treatment to ensure there are no abnormalities. If symptoms such as sudden weight loss, abdominal pain, vomiting, or difficulty breathing occur, medical personnel should be notified immediately. This medication has not been established as safe for children or pregnant women, so it should not be used in these populations. When storing the medication, keep it out of reach of children and store in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication is susceptible to air and humidity, so it must be stored in a tightly sealed container. It is advisable to keep the storage temperature at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness for a longer time.
Biconvex oval film-coated tablet in yellow to deep yellow color
30 tablets (6 tablets/Alu-Alu packaging), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Cheil Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.